Steve Kitchen, PhD

Lead Scientist
Sheffield Haemophilia and Thrombosis Centre
sheffield, England, United Kingdom

Steve Kitchen PhD Lead Clinical Scientist , Dept of Coagulation, Sheffield Haemophilia and Thrombosis Centre, Sheffield Teaching Hospitals. Centre is designated an International Haemophilia Training Centre by World Federation of Haemophilia


Scientific Director, UK National External Quality Assessment Scheme for Blood Coagulation

Director WFH International External Quality Assessment Schemes for Blood Coagulation

Vice president Haemostasis, International Council for Standardisation in Haematology.

Presentation(s):

• OC 15.4 - ADAMTS13 results for the SSC Plasma Standard from ECAT and UK NEQAS External Quality Assessment Programmes

  Sunday, June 25, 2023
  11:30 – 11:45 ET

• OC 23.5 - National External Quality Assessment Scheme (NEQAS BC) and Welsh Blood Service (WBS) use cold-stored platelets for External Quality Assessment (EQA) scheme for Light Transmission Aggregometry (LTA).

  Sunday, June 25, 2023
  15:45 – 16:00 ET

• PB0556 - Evaluation of the ACL TOP 970 CL analyser for clotting, chromogenic and immunoturbidimetric assays for thrombophilia

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0616 - UK National External Quality Assessment Scheme for Blood coagulation (UK NEQAS BC) evaluation of the point of care fibrinogen device

  Monday, June 26, 2023
  18:30 – 19:30 ET

• MC 27.1 - Laboratory Monitoring with New Hemophilia Therapies

  Tuesday, June 27, 2023
  07:00 – 07:45 ET

• PB1039 - Evaluation of External Quality Assessment material for activated clotting time on point of care devices: United Kingdom National External Quality Assessment Scheme for Blood Coagulation pilot studies.

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1041 - Evaluation of external quality assessment material on the renovated point of care device, United Kingdom National External Quality Assessment Scheme for Blood Coagulation studies.

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1105 - Post-infusion monitoring of Afstyla FVIII replacement therapy – data from the UK National External Quality assessment for Blood Coagulation (UK NEQAS BC) programme 2022.

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1112 - UK National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC) Emicizumab programme, survey July 2022 results for modified one-stage assay and chromogenic assay.

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1121 - Laboratory INRs determined with commercial thromboplastins in >450 centres before and after the establishment of the IRP for human thromboplastin - rTF 16 : Data from UK NEQAS for Blood Coagulation

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1135 - Evaluation of charcoal based direct oral anticoagulant (DOAC) neutralisation in the laboratory measurement of lupus anticoagulant (LA)

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1148 - Frozen plasmas can replace fresh plasmas in ISI calibrations for secondary thromboplastin standards for multiple reagent/instrument combinations

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1153 - Shortening of APTT when Heparin Neutralising Calcium Solution Replaces Calcium Alone is Highly Specific for the Presence of Heparin.

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1154 - Temporary isolated reagent-specific gross prolongation of APTT can be caused by acidosis

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1166 - The true effect of haemolysis interference on routine coagulation tests using paired matched samples performed on the Sysmex CN-series coagulation analyser

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1174 - Effect of haemolysis on coagulation tests as performed on HORIBA Yumizen G1550 Analyser. How HIL auto-check can help.

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• OC 77.6 - Progress in Hemostasis Testing: Implications for Future Practice

  Wednesday, June 28, 2023
  10:15 – 11:30 ET